Low molecular weight heparin biosimilar - Shenzhen Techdow Pharmaceuticals/Valeo Pharma
Alternative Names: LMWH biosimilar; LMWH biosimilar - Valeo Pharma; Redesca; Redesca HPLatest Information Update: 30 Apr 2021
At a glance
- Originator Techdow Pharmaceuticals
- Developer Valeo Pharma
- Class Anticoagulants; Antithrombotics; Low molecular weight heparins; Vascular disorder therapies
- Mechanism of Action Factor Xa inhibitors; Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Deep vein thrombosis; Pulmonary embolism; Thromboembolism